NCT02188888View on ClinicalTrials.gov

Echocardiographic and Arterial Pressure Waveform Changes After Reducing Heart Rate With Esmolol in Septic Shock Patients

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
TachycardiaSeptic Shock
Interventions
DRUG

esmolol

Strict heart rate control: esmolol at any dose to maintain heart rate between 95 and 80 bpm

Trial Locations (1)

00161

Department of Anesthesiology and Intensive care of the University of Rome La Sapienza, Rome

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT02188888 - Echocardiographic and Arterial Pressure Waveform Changes After Reducing Heart Rate With Esmolol in Septic Shock Patients | Biotech Hunter | Biotech Hunter